Accéder au contenu
Merck

A trypanocidal phenazine derived from beta-lapachone.

Journal of medicinal chemistry (2002-05-03)
Cleverson Neves-Pinto, Valéria R S Malta, Maria do Carmo F R Pinto, Regina H A Santos, Solange L de Castro, Antônio Ventura Pinto
RÉSUMÉ

An intensive effort has been directed toward finding alternative drugs for treatment of Chagas' disease, caused by Trypanosoma cruzi, and prophylaxis of blood in endemic areas. Our research comprises the synthesis and trypanocidal screening of derivatives from naphthoquinones. Herein a new phenazine, obtained from the reaction of beta-lapachone with aniline, has its structure established by physical data and X-ray analysis. It was 9 times more active against T. cruzi trypomastigotes than crystal violet.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
β-Lapachone, ≥98% (TLC)